February 6, 2008

Vanderbilt-Peruvian partnership addresses silent epidemic of diabetes; Center for the Americas collaboration provides multi-specialty approach

Mobile cameras, high-resolution digital imaging and funding from the Center for the Americas at Vanderbilt University are among the key components of a cross-cultural pilot program to prevent vision loss in at-risk Latin Americans.

By Vanderbilt Health News

December 18, 2007

Vanderbilt awarded $4.4 million by the Michael J. Fox Foundation

A drug discovery team at Vanderbilt University Medical Center led by Jeffrey Conn., Ph.D., has been awarded a $4.4 million “LEAPS” grant by the Michael J. Fox Foundation for Parkinson’s Research to jump-start development of a new class of Parkinson’s disease drugs.

December 18, 2007

Vanderbilt awarded $4.4 million by the Michael J. Fox Foundation; Goal is to develop new class of Parkinson’s disease drugs

A drug discovery team at Vanderbilt University Medical Center led by Jeffrey Conn has been awarded a $4.4 million “LEAPS” grant by the Michael J. Fox Foundation for Parkinson’s Research to jump-start development of a new class of Parkinson’s diseasedrugs.

By Bill Snyder

February 23, 2007

Vanderbilt-Ingram clinic space expanding to meet needs of patients

When the dust settles on a new renovation project involving Vanderbilt-Ingram Cancer Center‘s Henry-Joyce Cancer Clinic, waiting room space and exam rooms will nearly double to help meet the needs of an ever increasing number of cancer patients in Middle Tennessee and beyond.

December 9, 2005

Niswender named Culpeper Scholar

Vanderbilt University’s Kevin Niswender, M.D., Ph.D., has been named one of three 2006 Charles E. Culpeper Medical scholars, according to Goldman Philanthropic Partnerships.

By Vanderbilt Health News

June 15, 2005

Vanderbilt-Ingram Announces New Research Institute To Focus On Earliest Possible Detection Of Cancers

The Vanderbilt-Ingram Cancer Center will launch a new research institute, jump-started with a $10 million gift from West Tennessee businessman Jim Ayers, to develop techniques to detect cancers at their earliest, most curable stages, Vanderbilt officials announced today.

By Vanderbilt Health News